Next generation sequencing
RSTL2018011
Unknown other active
Quick answer
Next generation sequencing for Gastrointestinal Cancer is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Gastrointestinal Cancer
- Phase
- Unknown
- Modality
- other
- Status
- active